Peilin Zheng Selected Research

Sitagliptin Phosphate (Januvia)

3/2019

Altered T-cell subsets and transcription factors in latent autoimmune diabetes in adults taking sitagliptin, a dipeptidyl peptidase-4 inhibitor: A 1-year open-label randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peilin Zheng Research Topics

Disease

10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 03/2013
5	Latent Autoimmune Diabetes in Adults 06/2019 - 01/2016
4	Neoplasms (Cancer) 02/2020 - 01/2015
3	Fibrosis (Cirrhosis) 02/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2019
1	Pathologic Constriction (Stenosis) 05/2022
1	Ischemia 04/2022
1	Atrophy 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Alcoholic Fatty Liver 11/2020
1	Insulin Resistance 11/2020
1	Obesity 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 03/2020
1	Sepsis (Septicemia) 03/2020
1	Extranodal Extension 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Malaria 01/2019
1	Disease Progression 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 05/2015
1	DiGeorge Syndrome (Syndrome, DiGeorge) 05/2015
1	Infections 07/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2010
2	DisulfidesIBA 02/2022 - 01/2020
2	Oxidoreductases (Dehydrogenase)IBA 02/2022 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2021
2	LipidsIBA 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 06/2019 - 03/2019
2	AutoantibodiesIBA 01/2019 - 01/2019
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 04/2022
1	Streptozocin (Streptozotocin)FDA Link 04/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	C-PeptideIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	LuciferasesIBA 11/2021
1	Circular RNAIBA 11/2021
1	CollagenIBA 11/2021
1	Fibronectins (Fibronectin)IBA 11/2021
1	Methionine (L-Methionine)FDA Link 11/2020
1	Choline (Choline Chloride)IBA 11/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2020
1	Long Noncoding RNAIBA 03/2020
1	Biomarkers (Surrogate Marker)IBA 03/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 06/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2019
1	artemisinin (artemisinine)IBA 01/2019
1	TetraspaninsIBA 01/2019
1	AntigensIBA 01/2019
1	ArtesunateIBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	AntibodiesIBA 08/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	ProinsulinIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	To autoantigenIBA 01/2016
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 05/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Immune Checkpoint InhibitorsIBA 01/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2013
1	Tyrosine (L-Tyrosine)FDA Link 03/2013

Therapy/Procedure

2	Colectomy 02/2020 - 01/2020
2	Glycemic Control 03/2019 - 11/2018
2	Therapeutics 01/2018 - 08/2017
2	Immunotherapy 08/2017 - 01/2015
1	Carotid Endarterectomy 05/2022
1	Liver Transplantation 01/2022